Weights and Measures: Clinical Trials

8 trials of Weights and Measures, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 active not recruiting, 1 enrolling by invitation, 1 not yet recruiting. 8 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 4, Active not recruiting 2, Enrolling by invitation 1, Not yet recruiting 1
Phase 11Completed 1
Phase 31Completed 1

Follow Weights and Measures: new trials by email Literature Review of Weights and Measures trials Research Report on Weights and Measures

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate the Precision of ABL-101 Perfluorocarbon and Fluorine-19 MRI for the Mapping of Atherosclerotic Plaque Composition and Inflammation in Patients Undergoing Carotid Endarterectomy
ABL-101 is administered at 3mL/kg body weight (to a notional maximum of 100kg, rounded to the nearest ml), at the rate of 15 mL/min (900ml/hour). - Atherosclerotic Disease, Carotid, Carotid Endarterectomy
Phase 2Not yet recruitingRuud van Heeswijk182025-07-012025-02-27
Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery
Encapsulated amisulpride 50 mg (matched for color, weight, smell and size), Encapsulated placebo (matched for color, weight, smell and size) - Post Operative Nausea and Vomiting (PONV)
Phase 2Active not recruitingInstituto do Cancer do Estado de São Paulo2762025-04-102026-09-09
Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma
Rituximab, Lenalidomide 20 MG, Comprehensive Geriatric Assessment (CGA) - Chemotherapy, Diffuse Large B-Cell Lymphoma (DLBCL), Nos
Phase 2CompletedCentre Hospitalier Universitaire, Amiens12021-11-092026-06-12
Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in Obese Patients: Towards New Phenotypic Markers for an Optimized Care Pathway
fMRI, Indirect calorimetry, Bioimpedance - Obesity
Phase 2 / Phase 3CompletedRennes University Hospital472018-04-262023-08-01
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
Enzalutamide, assessment - Breast Cancer, Early Stage
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center502016-05-192026-06-24
Consumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos)
Initial in-person individual diet and exercise counseling (N vs. Y), Thrice weekly diet and exercise text messages (N vs. Y), Weekly telephone support (N vs. Y) - Overweight, Obesity
Phase 2Enrolling by invitationMemorial Sloan Kettering Cancer Center17852015-05-052026-07-06
A Virtual Support Pilot Program for Weight Loss Surgery Patients
Weight and Exercise Lifestyle Support (WELS), Usual Care - Weight, Physical Activity
Phase 1 / Phase 2CompletedBaystate Medical Center102013-01-012015-03-13
The Effects of Estrogen on Cognition in Girls With Turner Syndrome
cognitive tests and scales - Gonadal Dysgenesis, Turner's Syndrome
Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)9501990-05-012008-03-04

Conditions studied

Obesity (3)  ·  Body Weight (1)  ·  Breast Neoplasms (1)  ·  Carotid Artery Diseases (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Food Addiction (1)  ·  Gonadal Dysgenesis (1)  ·  Inflammation (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Motor Activity (1)  ·  Overweight (1)  ·  Postoperative Nausea and Vomiting (1)  ·  Recurrence (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Turner Syndrome (1)

Sponsors

Memorial Sloan Kettering Cancer Center (2)  ·  Baystate Medical Center (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Instituto do Cancer do Estado de São Paulo (1)  ·  Rennes University Hospital (1)  ·  Ruud van Heeswijk (1)

Countries

United States (4)  ·  France (2)  ·  Brazil (1)  ·  Switzerland (1)

Top investigators

Angela M Sousa, MD, MsC, PhD (1)  ·  Catherine Thieblemont, MD (1)  ·  David Val-Laillet, MSc, PhD, HDR (1)  ·  Fabrice Jardin, MD (1)  ·  Frederic Peyrade, MD (1)  ·  Isabelle Grulois, MD (1)  ·  Jennifer Leng, MD, MPH (1)  ·  Margot Robles, MD (1)